Allergan Eyelash Growth Drug Wins Over FDA Panel, Steps Closer To Approval
This article was originally published in The Rose Sheet
Executive Summary
FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously (9-0) Dec. 5 to recommend approval of Allergan's eyelash growth-stimulating drug, Latisse